Burjeel Holdings (ADX:BURJEEL) Research & Development: د.إ0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADX:BURJEEL Burjeel Holdings PLC ADX:BURJEEL
79 GF Score
Price د.إ1.07
GF Value د.إ2.54
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Burjeel Holdings Research & Development?

Burjeel Holdings ADX:BURJEEL -3.60% 79 Research & Development is د.إ0 Mil as of Mar. 2026. GuruFocus rates ADX:BURJEEL with a GF Score™ of 79/100 and a GF Value™ of د.إ2.54 (Significantly Undervalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Burjeel Holdings's Research & Development for the three months ended in Mar. 2026 was د.إ0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was د.إ0 Mil.

Burjeel Holdings  (ADX:BURJEEL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Burjeel Holdings Research & Development Related Terms

Burjeel Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Burjeel Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Burjeel Holdings Research & Development Chart

Burjeel Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Burjeel Holdings Quarterly Data
Mar21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ADX:BURJEEL
79GF Score
Burjeel Holdings PLC ADX:BURJEEL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Burjeel Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was د.إ0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of د.إ0 Mil mean?
Burjeel Holdings (ADX:BURJEEL) has a Research & Development of د.إ0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Burjeel Holdings and its competitors.
Is Burjeel Holdings' Research & Development too high?
Burjeel Holdings' current Research & Development is د.إ0 Mil. Overall, Burjeel Holdings has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Burjeel Holdings' Research & Development compare to HCA and THC?
Burjeel Holdings' Research & Development of د.إ0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Burjeel Holdings and its competitors. Burjeel Holdings's current Research & Development is د.إ0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Burjeel Holdings stock overvalued right now?
Based on GuruFocus' analysis, Burjeel Holdings (ADX:BURJEEL) is currently considered Significantly Undervalued. The stock's GF Value™ is د.إ2.54, compared to a current price of د.إ1.07 — trading 57.9% below its estimated fair value. The current Research & Development is د.إ0 Mil. Burjeel Holdings' overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Burjeel Holdings (ADX:BURJEEL), the current Research & Development is د.إ0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Burjeel Holdings (ADX:BURJEEL) Overvalued in 2026?

Based on GuruFocus' analysis, Burjeel Holdings stock appears to be undervalued. The current stock price of د.إ1.07 is trading 57.9% below its estimated GF Value™ of د.إ2.54. GuruFocus considers Burjeel Holdings to be Significantly Undervalued.

Key valuation signals for ADX:BURJEEL:

  • Research & Development: د.إ0 Mil
  • GF Value™: د.إ2.54 vs. price of د.إ1.07 (57.9% below fair value)
  • GF Score™: 79/100 with 6 warning signs

No single metric tells the full story. See the ADX:BURJEEL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Burjeel Holdings Business Description

Address 402-D02, Abu Dhabi Global Market Square, 15th Floor, Al Sarab Tower, Maryah Island, Abu Dhabi, ARE
Burjeel Holdings PLC is a healthcare service provider. Along with its subsidiaries, it provides multi-specialty hospitals, medical, surgical and dental services, and the sale of pharmaceutical goods and medical equipment. The group's reportable segments are Hospitals, Medical Centre, Pharmacies, and Others. Maximum revenue for the group is derived from the Hospitals segment, which includes entities that provide inpatient, day-care services, and outpatient services to patients to diagnosis the disease and offer medical and surgical treatment as part of in-patient services. Geographically it derives maximum revenue from its customers in the United Arab Emirates, followed by the Sultanate of Oman and the Kingdom of Saudi Arabia.
79GF Score

Get the complete analysis for ADX:BURJEEL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

د.إ1.07
Price
د.إ2.54
GF Value